Unknown PHASE3 INTERVENTIONAL 2-arm NCT00517257

Atorvastatin for the Treatment of Retinal Vein Occlusion (ATORVO)

Atorvastatin Toronto Retinal Vein Occlusion Study (ATORVO)

Sponsor: Canadian Heart Research Centre

Conditions Branch Retinal Vein Occlusion Central Retinal Vein Occlusion Retinal Vein Occlusion Retinal Vein Thrombosis Thrombosis

Interventions Atorvastatin Placebo

Updated 6 times since 2017 Last updated: Jun 23, 2008 Started: Aug 31, 2007 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Branch Retinal Vein Occlusion and Central Retinal Vein Occlusion and is currently ongoing. Canadian Heart Research Centre leads this study, which shows 6 recorded versions since 2007 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jan 2021 — Oct 2021 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Aug 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Canadian Heart Research Centre
Ontario Association of Optometrists
Pfizer
Toronto Ophthalmological Society
Unity Health Toronto
University of Toronto

Data source: University of Toronto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Toronto, Canada